Cervantes F, Ross DM, Radinoff A, Palandri F, et al. Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study. Leukemia 2021 Sep 2. pii: 10.1038/s41375-021-01396.
PMID: 34475521